Correlation of Ki-67, Mitotic Count, and PHH3 in Grading and Gastrointestinal Pancreatic Neuroendocrine Neoplasms

被引：0
|
作者：
Papanicolau-Segos, A. [1 ]
Murphy, C. E. [1 ]
McCormick, K. A. [1 ]
Upton, M. P. [1 ]
Shankaran, V. [1 ]
Westerhoff, M. [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
来源：
LABORATORY INVESTIGATION | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
802
引用
收藏
页码：197A / 197A
页数：1
相关论文
共 50 条
  • [31] Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies
    Puripat, Napaporn
    Loharamtaweethong, Kongsak
    VIRCHOWS ARCHIV, 2019, 474 (01) : 87 - 96
  • [32] Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma
    Ladstein, Rita G.
    Bachmann, Ingeborg M.
    Straume, Oddbjorn
    Akslen, Lars A.
    BMC CANCER, 2010, 10
  • [33] Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions
    Nasr, Michel R.
    El-Zammar, Ola
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2008, 30 (02) : 117 - 122
  • [34] Digital quantification of Ki-67 and PHH3 in the classification of uterine smooth muscle tumors
    Cao, Connie
    Omar, Jesus
    De Cotiis, Dan
    Richard, Scott
    Rosenblum, Norman
    Chan, Joanna
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S132 - S132
  • [35] Digital Quantification of Ki-67 and PHH3 in the Classification of Uterine Smooth Muscle Tumors
    Cao, Connie D.
    Rico-Castillo, Jesus
    De Cotiis, Dan
    Richard, Scott D.
    Rosenblum, Norman G.
    Chan, Joanna S. Y.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2021, 40 (06) : 549 - 555
  • [36] Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma
    Rita G Ladstein
    Ingeborg M Bachmann
    Oddbjørn Straume
    Lars A Akslen
    BMC Cancer, 10
  • [37] Ki-67 is a Better Prognostic Marker than Mitotic Count in Neuroendocrine Tumors
    Khan, M. S.
    El-Khouly, F.
    Toumpanakis, C.
    Meyer, T.
    Caplin, M.
    Luong, T., V
    NEUROENDOCRINOLOGY, 2011, 94 : 31 - 31
  • [38] Ki-67 Proliferation Index in Pancreatic Endocrine Tumors: Comparison with Mitotic Count, Interobserver Variability, and Impact on Grading
    Rege, T. A.
    King, E. E.
    Barletta, J. A.
    Bellizzi, A. M.
    MODERN PATHOLOGY, 2011, 24 : 372A - 372A
  • [39] Ki-67 Proliferation Index in Pancreatic Endocrine Tumors: Comparison with Mitotic Count, Interobserver Variability, and Impact on Grading
    Rege, T. A.
    King, E. E.
    Barletta, J. A.
    Bellizzi, A. M.
    LABORATORY INVESTIGATION, 2011, 91 : 372A - 372A
  • [40] Use of pHH3, Ki-67 and survivin immunoreactivity in the evaluation of fibroadenoma and phyllodes tumors of breast
    Shah, S. S.
    El-Zammar, O. A.
    MODERN PATHOLOGY, 2008, 21 : 53A - 53A
12345